Delivery Order SPE2DB24D2101-SPE2DB25FKHDF

Award Date 2/25/25
Potential Completion Date 2/26/25
Potential Value $27K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,525.48 firm fixed-price delivery order is for the drug Prolia 60 mg/ml syringe and has an ultimate completion date of December 24, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $21,967.08, is for the delivery of Prolia 60 mg/ml syringes. It is a firm fixed-price delivery order contract with a completion date of July 25, 2024. The contract is not designated as a set-aside. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,714.50 firm fixed-price delivery order is for PROLIA 60 MG/ML SYRINGEML, a prescription medication, with a period of performance through January 7, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order with a Firm Fixed Price valued at $31,449.70. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, to provide PROLIA 60 MG/ML SYRINGEML. The contract has an ultimate completion date of January 27, 2025 and does not have a set-aside designation, indicating it was an open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $3,943.09, is for the delivery of 4563902973 PROLIA 60 MG/ML syringe. The IDC held by Amerisourcebergen with the DLA is valued at $999,999,999 and runs through November 2026, providing a comprehensive range of pharmaceutical products and medical...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical for the delivery of Prolia 60 mg/mL syringes. The single-award contract has a ceiling value of $45,818.29 and runs through November 1, 2023. The contract is a Firm Fixed Price Delivery Order with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $5,761.01, is for the delivery of Prolia 60 mg/ml syringes. It is a firm fixed-price delivery order contract with a completion date of September 25, 2023. The contract is not set aside for any specific business type. Amerisourcebergen holds a significant Indefinite Delivery...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) under contract number SPE2DB22D1103/SPE2DB25FTEC6. The $15,504.29 firm-fixed-price delivery order is for the supply of PROLIA 60 MG/ML syringes, with a completion date of January 14, 2025. This award is not designated as a set-aside contract. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the supply of PROLIA 60 MG/ML SYRINGEML to the Defense Logistics Agency (DLA). The contract has a ceiling value of $13,887.54 and runs through April 25, 2024. It is a delivery order contract with a firm fixed price pricing type. The contract is not designated as a set-aside. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $11,260.68 firm fixed-price delivery order is for the supply of Prolia 60 mg/mL syringes. The award has an ultimate completion date of September 27, 2024. Amerisourcebergen holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999 through December 2025, which...
  • SPE2DB24D2101
    Indefinite Delivery Contract
  • SPE2DB24D2101-SPE2DB25FKHDF
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $26,531.23 firm fixed-price delivery order is for Prolia 60 mg/ml syringes, a specialty medication, with a period of performance through February 2025.

Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract award did not utilize any set-aside designations. Amerisourcebergen also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, covering similar medical products and prescription drugs.

Generated 5/27/25, 9:53 AM